Skip to content
10-Q

Quarterly Report

BioLife Solutions, Inc. BLFS

0001628280-25-050190

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 48.15M sh
Shares Diluted Q3 2025 · Sep 30, 2025 48.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 47.62M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.18M sh
Shares Diluted Q3 2025 · Sep 30, 2024 45.87M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 $15.2M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $6.79M
Long Term Debt Q3 2025 · Sep 30, 2025 $0
Long Term Debt Q3 2025 · Dec 31, 2024 $5M
Short Term Debt Q3 2025 · Sep 30, 2025 $7.49M
Short Term Debt Q3 2025 · Dec 31, 2024 $10.94M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $29.48M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $95.39M
Stockholders Equity Q3 2025 · Sep 30, 2025 $353.74M
Stockholders Equity Q3 2025 · Jun 30, 2025 $347.16M
Stockholders Equity Q3 2025 · Dec 31, 2024 $348.91M
Stockholders Equity Q3 2025 · Sep 30, 2024 $325.46M
Stockholders Equity Q3 2025 · Jun 30, 2024 $321.44M
Stockholders Equity Q3 2025 · Dec 31, 2023 $337.66M
Current Liabilities Q3 2025 · Sep 30, 2025 $27.15M
Current Liabilities Q3 2025 · Dec 31, 2024 $32.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $38.34M
Total Liabilities Q3 2025 · Dec 31, 2024 $50.58M
Current Assets Q3 2025 · Sep 30, 2025 $126.57M
Current Assets Q3 2025 · Dec 31, 2024 $148.76M
Total Assets Q3 2025 · Sep 30, 2025 $392.08M
Total Assets Q3 2025 · Dec 31, 2024 $399.49M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.01
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.33
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.71
Eps Basic Q3 2025 · Sep 30, 2025 $0.01
Eps Basic Q3 2025 · Sep 30, 2025 −$0.33
Eps Basic Q3 2025 · Sep 30, 2024 −$0.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.71
Sga Expense Q3 2025 · Sep 30, 2025 $12.07M
Sga Expense Q3 2025 · Sep 30, 2025 $34.97M
Sga Expense restated Q3 2025 · Sep 30, 2024 $9.33M
Sga Expense restated Q3 2025 · Sep 30, 2024 $29.04M
Rd Expense Q3 2025 · Sep 30, 2025 $2.71M
Rd Expense Q3 2025 · Sep 30, 2025 $7.63M
Rd Expense restated Q3 2025 · Sep 30, 2024 $1.89M
Rd Expense restated Q3 2025 · Sep 30, 2024 $6M
Net Income Q3 2025 · Sep 30, 2025 $621K
Net Income Q3 2025 · Sep 30, 2025 −$15.67M
Net Income Q3 2025 · Sep 30, 2024 −$1.7M
Net Income Q3 2025 · Sep 30, 2024 −$32.64M
Operating Income Q3 2025 · Sep 30, 2025 −$89K
Operating Income Q3 2025 · Sep 30, 2025 −$17.95M
Operating Income restated Q3 2025 · Sep 30, 2024 −$418K
Operating Income restated Q3 2025 · Sep 30, 2024 −$5.02M